Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Matrine sustained-release tablets in HBeAg-positive chronic hepatitis B
CTR20132493Phase 2Completed
- Sponsor
- Shandong Yikang Pharmaceutical Co., Ltd.
- Start
- Jan 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of matrine in Chronic Hepatitis B (CHB), sponsored by Shandong Yikang Pharmaceutical Co., Ltd.. Started Jan 2014; status: completed.
02
Drugs
matrine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20132493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132493.